With a focus on actionable insights and strategic value, The Business Research Company’s 2026 market reports include market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights.
How Large Could The Artificial Intelligence In Epidemiology Market Become By 2030 At A 30.7% CAGR?
The artificial intelligence in epidemiology market size has experienced rapid expansion in recent years. This market is projected to expand from $0.83 billion in 2025 to $1.09 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 30.0%. Historically, this growth has been driven by factors such as the rise in infectious disease outbreaks, greater access to health data, the integration of digital public health instruments, governmental emphasis on disease surveillance, and the imperative for quicker outbreak responses.
The artificial intelligence in epidemiology market is projected to experience substantial expansion over the coming years, reaching a valuation of $3.17 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 30.7%. This growth during the projected period stems from factors such as increasing investment in AI for public health initiatives, the proliferation of cloud-based epidemiology platforms, a heightened need for early warning systems, the consolidation of health data from various sources, and an increased emphasis on preparing for pandemics. Key developments anticipated within this forecast timeframe encompass AI-powered disease outbreak forecasting, real-time systems for epidemiological surveillance, sophisticated population health analytics, predictive models designed for public health planning, and unified data platforms specifically for epidemiology.
Get A Free Artificial Intelligence In Epidemiology Market Sample With 2030 Forecast Insights:
Artificial Intelligence In Epidemiology Market Outlook: Key Driver Supporting Long-Term Growth
The increasing prevalence of chronic illnesses is anticipated to drive the expansion of artificial intelligence within the epidemiology market in the future. A chronic disease is defined as a persistent or enduring health ailment or condition, typically persisting for at least three months, which can progressively worsen. Artificial intelligence holds a crucial function across multiple facets of chronic disease epidemiology, encompassing the forecasting of risks, modeling of disease advancement, timely identification, and accurate diagnosis. For example, in May 2023, The United Nations (UN), a US-based intergovernmental organization dedicated to fostering international cooperation and preserving global peace and security, reported that chronic diseases contribute to seven out of 10 fatalities in the US, resulting in over 1.7 million American deaths annually. Consequently, the escalating impact of chronic diseases is projected to boost the development of artificial intelligence in the epidemiology market.
Segmentation Of The Artificial Intelligence In Epidemiology Market: Key Categories Explained
The artificial intelligence in epidemiology market covered in this report is segmented –
1) By Component: Software, Services
2) By Deployment: Web-Based, Cloud-Based
3) By Application: Infection Prediction And Forecasting, Disease And Syndromic Surveillance
4) By End-Use: Government And State Agencies, Research Laboratories, Pharmaceutical And Biotechnology Companies, Healthcare Providers
Subsegments:
1) By Software: Data Analytics Platforms, Predictive Modeling Tools, Geographic Information Systems (GIS), Surveillance Systems, Reporting And Visualization Tools
2) By Services: Consulting Services, Implementation And Integration Services, Data Management And Support Services, Training And Capacity Building Services
Artificial Intelligence In Epidemiology Market Evolving Trends: What Businesses Should Know
Leading firms within the artificial intelligence in epidemiology market are focusing on developing advanced technologies, including AI-powered imaging platforms for managing diseases, to maintain their competitive standing. As an example, in April 2023, Twinn Health, a US-based company specializing in fitness, AI, and machine learning, introduced an AI-driven imaging platform aimed at the early detection of age-related diseases. This new platform marks the first instance of integrating magnetic resonance imaging (MRI) data for assessing the risk of frailty. It serves as an effective instrument for early intervention and prevention because it can identify chronic age-related conditions sooner than traditional molecular indicators, thus facilitating their management at an initial phase.
Who Competes In The Artificial Intelligence In Epidemiology Market? Major Companies Listed
Major companies operating in the artificial intelligence in epidemiology market are Alphabet Inc.; Microsoft Corporation; Roche Holding AG; Pfizer Inc.; Johnson & Johnson Services Inc.; Amazon Web Services Inc.; Google LLC; Intel Corporation; IBM Corporation; Merck & Co. Inc.; Novartis International AG; Sanofi S.A; Bristol Myers Squibb Company; AstraZeneca PLC; Oracle Corporation; GlaxoSmithKline plc; NVIDIA Corporation; Bayer Healthcare; Siemens Healthineers AG; Koninklijke Philips N.V.; SAS Institute Inc.; Epic Systems Corporation; Cerner Corporation; eClinicalWorks LLC; Meditech; Komodo Health; Metabiota Inc.
Read The Complete Artificial Intelligence In Epidemiology Market Forecast Report Through 2030:
Artificial Intelligence In Epidemiology Market Regional Ranking: Which Geography Comes First?
North America was the largest region in the artificial intelligence in epidemiology market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial intelligence in epidemiology market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Wasay has over a decade of experience in market research, data modelling, and analytics, with prior experience at GlobalData and Decision Tree Consulting Services. At The Business Research Company , he leads research operations across syndicated studies, customized consulting engagements, and the Global Market Model platform. His professional experience includes supporting organizations such as Boston Consulting Group, KPMG, and Ernst & Young. Wasay holds a degree in Electronics and Communications Engineering, postgraduate management qualifications from International Management Institute Belgium and Indian School of Business and Entrepreneurship, and completed the Integrated Program in Business Analytics from Indian Institute of Management Indore.
